$4.99
-0.25-4.77%
In chiusura: Nov 17, 4:00 PM EST
$4.85
-0.39-7.44%
Pre-mercato: 6:08 AM EST

aTyr Pharma (ATYR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-7.43 | $-4.08 | -82.1 % |
| Q2 | Aug 7, 2026 | $-4.40 | $-4.80 | 8.33 % |
| Q1 | May 15, 2026 | $-4.40 | $-6.00 | 26.7 % |
| Q4 | Mar 5, 2026 | $-5.60 | $-7.20 | 22.2 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | May 15, 2026 | $0 | $20.00K | -100.0 % |
| Q4 | Mar 5, 2026 | $0 | $20.00K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $4.80M | -100.0 % |
| Q3 | Nov 7, 2024 | $0 | $20.00K | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.08 | $-4.80 | $-6.00 | $-7.20 |
| Actual | $-7.43 | $-4.40 | $-4.40 | $-5.60 |
| Surprise | -82.1% | +8.33% | +26.7% | +22.2% |
| Revenue | ||||
| Estimate | — | — | $20000 | $20000 |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-32.71 | $-60.85 | $-6.18 |
| Revenue | |||
| Consensus | — | — | — |